TPBG antibody, and preparation method, conjugate and application thereof

An antibody and sequence technology, applied in the field of TPBG antibody and its preparation, can solve the problems of non-cancerous cell damage and the limitation of killing effect.

Active Publication Date: 2017-07-04
KAIHUI SCI & TECH DEV SHANGHAI
View PDF3 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In clinical practice, although therapeutic antibodies have good targeting, their killing effects are limited
Although small molecule chemical drugs have a highly effective killing effect on cancer cells, they can also cause the same damage to non-cancer cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • TPBG antibody, and preparation method, conjugate and application thereof
  • TPBG antibody, and preparation method, conjugate and application thereof
  • TPBG antibody, and preparation method, conjugate and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0198] The preparation of embodiment 1TPBG antibody

[0199] The nucleotide sequence containing the amino acid sequence 32-355 (Ser32-Ser355) of the extracellular region encoding the human source TPBG protein (wherein the nucleotide sequence encoding the human source TPBG protein is Genebank ID: AAH37161.1 in Genebank) Cloning into pCpC vector (purchased from Invitrogen, V044-50) carrying human IgG Fc fragment (hFc) and plasmid preparation according to established standard molecular biology methods. For specific methods, see Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, Second Edition (Plainview, New York: Cold Spring Harbor Laboratory Press). HEK293 cells (purchased from Invitrogen) were transiently transfected (polyetherimide PEI, purchased from Polysciences) and expanded at 37° C. using FreeStyle™ 293 (purchased from Invitrogen). After 4 days, the cell culture fluid was collected, and the cell components were removed by centr...

Embodiment 2

[0217] Example 2 Production and Purification of Lead Antibody

[0218] The concentration of antibodies produced by hybridoma cells is low, only about 1-10 μg / mL, and the concentration varies greatly. Moreover, various proteins produced by cell culture in the culture medium and fetal bovine serum components contained in the culture medium have varying degrees of interference with many biological activity analysis methods, so small-scale (1-5 mg) antibody production and purification are required.

[0219] The hybridoma cells obtained in Example 1 were inoculated into T-75 cell culture flasks and acclimatized and passaged for 3 generations with a production medium (Hybridomaserum free medium, purchased from Invitrogen). When the growth state is good, inoculate the cell culture spinner bottle. Add 200mL of production medium to each 2-liter culture spinner bottle, and inoculate the cell density at 1.0╳10 5 / mL. Close the bottle cap tightly, and place the spinner bottle on a spin...

Embodiment 3

[0225] The assay of embodiment 3 leading antibody

[0226] A. Enzyme-linked immunosorbent assay (ELISA) to detect the binding of TPBG antibody to TPBG protein

[0227] The purified TPBG antibody obtained in Example 2 was reacted with human TPBG-hFc protein (immunogen A).

[0228] Dilute the purified immunogen A obtained in Example 1 (see Example 1 step (1) for its preparation method) with PBS to a final concentration of 1.0 μg / mL, and then add 100 μL per well to a 96-well ELISA plate. Seal with plastic film Incubate overnight at 4°C, wash the plate twice the next day with plate washing solution [PBS containing 0.01% (v / v) Tween20], add blocking solution [containing 0.01% (v / v) Tween20 and 1% (w / w) PBS of BSA] blocked at room temperature for 2 hours. Pour off the blocking solution, add the purified TPBG antibody 100 μ L per well of the gained Example 2. After incubation for 2 hours at 37° C., wash the plate with the plate washing solution [containing 0.01% (v / v) Tween20 in P...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to view more

Abstract

The invention discloses a TPBG antibody, and a preparation method, a conjugate and an application thereof. The TPBG antibody comprises one or more of a heavy chain CDR1, a heavy chain CDR2 and a heavy chain CDR3 in the heavy chain variable region of the TPBG antibody, and / or one or more of a light chain CDR1, a light chain CDR2 and a light chain CDR3 of the light chain variable region of the TPBG antibody, and the amino acid sequences of all above heavy chains and light chains are respectively shown in the description. The TPBG antibody is a humanized antibody and has high affinity, and the conjugate prepared by coupling the TPBG antibody with a micro-molecular drug toxin MMAF has a cytotoxin killing effect on TPBG positive cells, so the conjugate can be used in the preparation of tumor treatment drugs.

Description

technical field [0001] The present invention relates to the field of antibodies, in particular to a TPBG antibody, its preparation method, its conjugate and its application. Background technique [0002] A cell surface molecule, trophoblast-specific glycoprotein (TPBG, also known as 5T4), was found to be a specific protein expressed by embryonic trophoblasts when comparing embryonic stem cell trophoblasts with cancer cells. The human TPBG protein has a molecular weight of about 72kDa and contains 420 amino acids. Its N-terminal oligosaccharide structure has diversity, which can prevent proteolysis and interact with other molecules in the process of cell membrane signal transduction. The TPBG protein contains seven repeating leucine domains (LRRs), which can participate in protein-protein interactions. [0003] The trophoblast is a layer of special embryonic stem cells between the placenta and the fetus, and TPBG is widely expressed in various trophoblast cells during embryo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/32C12N15/13G01N33/574G01N33/569A61K47/68A61K45/00A61K38/08A61P35/00
CPCA61K31/4025A61K45/00C07K16/00G01N33/57423G01N2500/10G01N2510/00A61K2039/505A61K47/6803A61K47/6851A61K47/6877A61P35/00C07K16/30C07K2317/24C07K2317/33C07K2317/92
Inventor 孙晓岚张莹张瑜胡飞飞宫世勇刘礼乐
Owner KAIHUI SCI & TECH DEV SHANGHAI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap